Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.4250 (6.37%) ($6.4250 - $6.4250) on Thu. Aug. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.93% (three month average) | RSI | 54 | Latest Price | $6.4250(6.37%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | TGTX declines -3.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(77%) ARKG(73%) IBB(71%) XLC(68%) ARKK(67%) | Factors Impacting TGTX price | TGTX will decline at least -3.465% in a week (0% probabilities). UUP(-40%) TBT(-28%) USO(-4%) XOP(-2%) XLE(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.465% (StdDev 6.93%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.95(7.98%) | 10 Day Moving Average | $6.16(4.3%) | 20 Day Moving Average | $6.12(4.98%) | To recent high | -18.8% | To recent low | 72% | Market Cap | $814m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |